Live Breaking News & Updates on Company american depositary

Stay informed with the latest breaking news from Company american depositary on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Company american depositary and stay connected to the pulse of your community

Biophytis Announces Transfer of ADSs to OTC Market

Biophytis / Key word(s): MiscellaneousBiophytis Announces Transfer of ADSs to OTC Market 24-Apr-2024 / 23:00 CET/CESTBiophytis Announces Transfer of ADSs to OTC Market  ADSs delisted from Nasdaq, which will result in meaningful savings ADSs transferred to OTC Pink market; Company will apply to trade on OTCQB ma...

United-states , France , Cambridge , Cambridgeshire , United-kingdom , Paris , France-general- , Massachusetts , American , French , Nicolas-fellmann , Antoine-denry

36Kr : Receives Approval to Transfer to The Nasdaq Capital Market - Form 6-K

36Kr Receives Approval to Transfer to The Nasdaq Capital Market

April 24, 2024

BEIJING, CHINA, April 24, 2024 - 36Kr Holdings Inc. , a prominent brand and a...

Beijing , China , United-states , American , Jenny-cai , Brandi-piacente , Nasdaq , Company-or-we , Company-american-depositary , Company-adss , Nasdaq-stock-market , Kr-holdings-inc

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - April 19, 2024

SAN MATEO, Calif. and SINGAPORE - ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today...

United-states , California , Singapore , American , Emma-thompson , Ashleyr-robinson , Linkedin , Letter-for-the-company , Spurwing-communications , Company-annual-report-on-form , Exchange-commission , Pharmaceuticals-nasdaq

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused b...

United-states , Singapore , California , American , Emma-thompson , Ashleyr-robinson , Linkedin , Letter-for-the-company , Nasdaq , Commission-file-no , Company-american-depositary , Exchange-commission-on

ASLAN Pharmaceuticals (ASLN) Receives Nasdaq Non-compliance Notice

ASLAN Pharmaceuticals (ASLN) Receives Nasdaq Non-compliance Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Company-american-depositary , Nasdaq , Aslan-pharmaceuticals-nasdaq , Company-form , Letter-for-the-company , Nasdaq-stock-market , Nasdaq-listing-rule , Nasdaq-capital-market , Stockholder-equity

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Singapore , American , Emma-thompson , Ashleyr-robinson , Company-form , Nasdaq , Letter-for-the-company , Linkedin , Company-us-securities , Company-american-depositary

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

SAN MATEO, Calif. and SINGAPORE, April 19, 2024 -- ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of...

California , United-states , Singapore , American , Emma-thompson , Ashleyr-robinson , Company-american-depositary , Linkedin , Commission-file-no , Lifesci-advisors , Nasdaq , Company-form

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it received a letter (the “Letter”) on April 18, 2024 from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it failed to maintain the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Mark

United-states , California , Singapore , American , Emma-thompson , Ashleyr-robinson , Nasdaq , Lifesci-advisors , Exchange-commission-on , Company-form , Pharmaceuticals-nasdaq , Company-american-depositary

Yunji Receives Approval to Transfer to Nasdaq Capital Market

Yunji Receives Approval to Transfer to Nasdaq Capital Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , United-states , Hangzhou , Zhejiang , American , Chinese , Robin-yang , Exchange-commission , Nasdaq-stock-market , Listing-qualifications-department , Company-american-depositary , Company-adss

XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K -April 02, 2024 at 04:09 pm EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

...

United-states , Washington , Israel , Ramat-gan , Tel-aviv , American , Shlomo-shalev , Biopharmaceuticals-ltd , Nasdaq , Securities-exchange , Company-american-depositary , Commission-file-number